The inhibitory effects of cisplatin‑radiation combination treatment on malignant osteosarcoma MG‑63 cells and BRCA1‑p53 pathways are more efficient than single treatments

作者: Hong‑Bin Sun , He‑Yuan Wang , Bing Wu , Zhong‑Feng Wang , Li‑Zhe Wang

DOI: 10.3892/OL.2019.11019

关键词:

摘要: The poor prognosis of patients with osteosarcoma remains a persistent problem, in particular for unresectable tumors or metastasis. Therefore, combination radiotherapy and chemotherapy has been considered metastasis recurrence, unsuitable surgery refusing surgery. present study aimed to investigate the effect combined treatment cisplatin radiation therapy on biological characteristics cell line MG-63 breast cancer 1 (BRCA1)-associated signaling pathways. Cell proliferation was determined using Counting kit-8 assay, apoptosis cycle were assessed by flow cytometry. migration examined Transwell assay. mRNA protein expression levels candidate genes, including BRCA1 p53, reverse transcription-quantitative PCR western blotting, respectively. results demonstrated that significantly inhibited compared alone. Furthermore, radiation, increased rate cells, which resulted G2 phase arrest, decreased migratory capacity cells. In addition, cells following higher group, but lower group. p53. Additionally, had more potent inhibitory p53 than expression. Bax level inductive Bcl-2 treatments exhibited superior therapeutic effects alone, may be mediated BRCA1-p53 pathway.

参考文章(53)
G Bacci, S Lari, Adjuvant and neoadjuvant chemotherapy in osteosarcoma. La Chirurgia Degli Organi Di Movimento. ,vol. 86, pp. 253- 268 ,(2001)
Rudolf Schwarz, Oyvind Bruland, Anna Cassoni, Paula Schomberg, Stefan Bielack, The role of radiotherapy in oseosarcoma. Cancer treatment and research. ,vol. 152, pp. 147- 164 ,(2009) , 10.1007/978-1-4419-0284-9_7
Geoff Delaney, Susannah Jacob, Carolyn Featherstone, Michael Barton, The role of radiotherapy in cancer treatment Cancer. ,vol. 104, pp. 1129- 1137 ,(2005) , 10.1002/CNCR.21324
Nicholas Turner, Andrew Tutt, Alan Ashworth, Hallmarks of 'BRCAness' in sporadic cancers Nature Reviews Cancer. ,vol. 4, pp. 814- 819 ,(2004) , 10.1038/NRC1457
Akira Matsunobu, Reiko Imai, Tadashi Kamada, Takeshi Imaizumi, Hiroshi Tsuji, Hirohiko Tsujii, Yoshiyuki Shioyama, Hiroshi Honda, Shin-ichiro Tatezaki, , Impact of carbon ion radiotherapy for unresectable osteosarcoma of the trunk Cancer. ,vol. 118, pp. 4555- 4563 ,(2012) , 10.1002/CNCR.27451
S. Hallam, S. Govindarajulu, B. Huckett, A. Bahl, BRCA1/2 Mutation-associated Breast Cancer, Wide Local Excision and Radiotherapy or Unilateral Mastectomy: A Systematic Review Clinical Oncology. ,vol. 27, pp. 527- 535 ,(2015) , 10.1016/J.CLON.2015.06.001
Stefano Ferrari, Massimo Serra, An update on chemotherapy for osteosarcoma Expert Opinion on Pharmacotherapy. ,vol. 16, pp. 2727- 2736 ,(2015) , 10.1517/14656566.2015.1102226
Binghao Li, Zhaoming Ye, Epigenetic alterations in osteosarcoma: promising targets Molecular Biology Reports. ,vol. 41, pp. 3303- 3315 ,(2014) , 10.1007/S11033-014-3193-7
Fausto Petrelli, Agostina De Stefani, Francesco Raspagliesi, Domenica Lorusso, Sandro Barni, Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: A systematic review and meta-analysis Gynecologic Oncology. ,vol. 134, pp. 166- 171 ,(2014) , 10.1016/J.YGYNO.2014.04.049